Medicare Enrolled
Dr. Akshay Shah, M.D.
Neurology · San Jose, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Akshay Shah is a neurology specialist in San Jose, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 734 Medicare services across 609 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $5,892 from 62 pharmaceutical and/or device companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 38% volume in CA
$5,892 industry payments
Medicare Practice Summary
Medicare Utilization ↗734
Medicare services
Top 38% in CA for neurology
609
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $112 | $190 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
91 | $67 | $125 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
88 | $113 | $204 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $145 | $251 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
40 | $157 | $236 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
39 | $99 | $198 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
38 | $188 | $399 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
33 | $52 | $778 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
17 | $287 | $441 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
16 | $96 | $123 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
12 | $48 | $521 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,892
Total received (2018-2024)
Avg $842/year across 7 years
Top 30% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
196
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,727 (97.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (2.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,088
2023
$794
2022
$688
2021
$1,286
2020
$387
2019
$642
2018
$1,007
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Inspire Medical Systems, Inc.
$169
Lundbeck LLC
$168
UCB, Inc.
$139
ABBVIE INC.
$111
Biogen, Inc.
$65
LivaNova USA, Inc.
$54
Genentech USA, Inc.
$50
Eisai Inc.
$42
JAZZ PHARMACEUTICALS INC.
$39
PFIZER INC.
$38
CATALYST PHARMACEUTICALS, INC.
$38
Teva Pharmaceuticals USA, Inc.
$38
Lilly USA, LLC
$27
ARGENX US, INC.
$26
Avadel CNS Pharmaceuticals, LLC
$25
HARMONY BIOSCIENCES LLC
$24
Octapharma USA, Inc.
$22
Celgene Corporation
$15
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$735
UCB, Inc.
$433
Biogen, Inc.
$344
AbbVie Inc.
$273
Teva Pharmaceuticals USA, Inc.
$235
Alexion Pharmaceuticals, Inc.
$235
Lundbeck LLC
$219
ABBVIE INC.
$169
Inspire Medical Systems, Inc.
$169
Amgen Inc.
$155
Neurocrine Biosciences, Inc.
$146
Abbott Laboratories
$143
Eisai Inc.
$140
Lilly USA, LLC
$139
CSL Behring
$136
Akcea Therapeutics, Inc.
$113
Sunovion Pharmaceuticals Inc.
$112
Biohaven Pharmaceuticals, Inc.
$96
EISAI INC.
$96
ACADIA Pharmaceuticals Inc
$95
Biohaven Pharmaceutical Holding Company Ltd.
$85
Bausch Health US, LLC
$85
SK Life Science, Inc.
$83
Adamas Pharmaceuticals, Inc.
$73
MDD US Operations, LLC
$72
JAZZ PHARMACEUTICALS INC.
$69
HARMONY BIOSCIENCES LLC
$65
ARGENX US, INC.
$64
Harmony Biosciences LLC
$61
Allergan, Inc.
$60
Janssen Pharmaceuticals, Inc
$58
Greenwich Biosciences, Inc.
$57
US WorldMeds, LLC
$53
Genentech USA, Inc.
$50
GENZYME CORPORATION
$49
Novartis Pharmaceuticals Corporation
$43
Allergan Inc.
$42
Acorda Therapeutics, Inc
$42
Amneal Pharmaceuticals LLC
$41
PFIZER INC.
$38
CATALYST PHARMACEUTICALS, INC.
$38
NeuroPace, Inc.
$31
Catalyst Pharmaceuticals, Inc.
$31
Sumitomo Pharma America, Inc.
$30
Horizon Therapeutics plc
$26
Resmed Corp
$25
Avanir Pharmaceuticals, Inc.
$25
Avadel CNS Pharmaceuticals, LLC
$25
Otsuka America Pharmaceutical, Inc.
$24
AQUESTIVE THERAPEUTICS, INC.
$24
Merz Pharmaceuticals, LLC
$23
BOSTON SCIENTIFIC CORPORATION
$23
Takeda Pharmaceuticals U.S.A., Inc.
$22
Octapharma USA, Inc.
$22
Merck Sharp & Dohme Corporation
$22
Jazz Pharmaceuticals Inc.
$20
UPSHER-SMITH LABORATORIES LLC
$20
Medtronic, Inc.
$19
Scilex Pharmaceuticals Inc.
$17
Boston Scientific Corporation
$17
AbbVie, Inc.
$17
Celgene Corporation
$15
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVALUS · Aimovig · AirFit · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · DUOPA · Dayvigo · Duopa · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FYCOMPA · Fycompa · GATTEX · GENERAL DBS · GENERAL - DBS · GOCOVRI · Hizentra · INBRIJA · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LUMRYZ · Leqembi · MIGRANAL · Merlin Connectivity and Remote · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · ONFI · Ocrevus · PANZYGA · Ponvory · QULIPTA · REXULTI · RNS System · RYTARY · Rystiggo · SOLIRIS · SYMPAZAN · TEGSEDI · TOSYMRA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · Xadago · Xeomin · ZEPOSIA · ZINBRYTA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
224
Per 100K population
11.8
County median income
$159,674
Nearest hospital
REGIONAL MEDICAL CENTER OF SAN JOSE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 303 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $5,892 from 62 companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other neurologists in San Jose?
Dr. Shah's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in San Jose
Browse neurologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology